Table 3.

Self-efficacy^a and response-efficacy^b (N = 355).

Confidence in ability to:	Vaccinatorsc (N = 304)	Non-vaccinators (N = 51)	p-value
	Mean (SD)	Mean (SD)
Prevent HPV without vaccine	30.0 (29.2)	64.1 (23.9)	<0.0001
Prevent HPV with vaccine	82.8 (18.5)	51.7 (30.5)	<0.0001
Vaccinate against HPV without severe side effects	74.8 (25.5)	29.3 (29.9)	<0.0001
Research risks and benefits of HPV vaccination	81.4 (19.1)	67.4 (29.6)	0.002
Prevent meningitis without vaccine	31.8 (29.6)	49.2 (32.4)	0.0006
Prevent meningitis with vaccine	81.1 (19.1)	62.4 (30.0)	<0.0001

HPV, human papillomavirus.

^aSelf-efficacy: Confidence in one's ability to prevent disease.

^bResponse-efficacy: Confidence in the vaccine's ability to prevent disease.

^cVaccinated includes HPV vaccine series initiated and those who plan to vaccinate.